0 212

Cited 0 times in

Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+ gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03

Authors
 Yelena Y. Janjigian  ;  Do-Youn Oh  ;  Sun Young Rha  ;  Keun Wook Lee  ;  Neeltje Steeghs  ;  Yee Chao  ;  Maria Di Bartolomeo  ;  Marc Díez Garcia  ;  Nadia Haj Mohammad  ;  Alexander Stein  ;  William McAdoo  ;  Megan Winter  ;  Liz Croydon  ;  Jeeyun Lee 
Citation
 JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 Suppl) : 295, 2022-02 
Journal Title
JOURNAL OF CLINICAL ONCOLOGY
ISSN
 0732-183X 
Issue Date
2022-02
Full Text
https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.295
DOI
10.1200/JCO.2022.40.4_suppl.295
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
Yonsei Authors
Rha, Sun Young(라선영) ORCID logo https://orcid.org/0000-0002-2512-4531
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/194452
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links